Polikliniğimize Kilo Vermek İçin Başvuran Hastalarda Etiyoloji ve Risk Faktörlerinin Belirllenmesi
Öz
Çalışmada Ankara İli Sağlık Bilimleri Üniversitesi Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi İç Hastalıkları Polikliniği’ne 01 Aralık 2016- 01 Haziran 2017 tarihleri arasında kilo verme isteğiyle başvurmuş 100 hastanın arşiv bilgileri incelenmiştir. Dışlanma kriterleri dışında kalan ve VKİ ≥ 25 kg/m2 olan hastalar çalışmaya alınmıştır. İç Hastalıkları Polikliniği’ nin rutin işleyişinde hasta dosyalarına kaydedilen yaş, cinsiyet, özgeçmiş, kan basıncı, antropometrik ölçümlerve laboratuvar verileri kullanılmıştır. Ölçüm ve kan tetkikleri en az 8 saatlik açlık sonrası sabah saatlerinde yapılmıştır. Araştırmanın verileri Statistical Package for the Social Sciences (SPSS) istatistik paket programı kullanılarak analiz edildi.
Boy E: 178,00(165-186),K: 161,00(150-185) (p<0,001) ve vücut ağırlığı E: 100,00(76-134) , K: 87,00(66-140) (p<0,001) . Bel/kalça çevresi oranı E: 0,88±0,09 , K: 0,83±0,06 bulundu (p=0,02). TPG K:94,00(61-218), E:101,00(70-219) (p=0,05) . HDL E: 41,00(28-141) , K: 48,00(31-78) (p=<0,01). Vitamin B12 K: 215,00(97-1500) , E: 188,00(107-394) (p:0,04) .
HOMA IR açısında Fazla Kilolu: 1.57 (0. 5-5. 7), Evre 1 Obez: 2.19 (0.55-20.20) , Evre 2 Obez: 2.80 (1.09- 12. 7) , Evre 3 Obez: 3.06 (0.42-6.2) (p:0.002) .
Bel çevresi; fazla kilolu: 89,86±10,71, Evre 1: 95,30±16,51, Evre 2: 104,52±9,04 , Evre 3 obez : 114,88±11,75 ( p<0,001). Kalça çevresi; fazla kilolu: 107,0(97-125), Evre 1: 114,0(96-134), Evre 2: 125,0(101-140) ,Evre 3: 130,0(111-150) (
Determination of Etiology and Risk Factors in Patients Applying to Our Outpatient Clinic for Weight Loss
Abstract
Archive information of 100 patients who applied to Ankara University Health Sciences University Dışkapı Yıldırım Beyazıt Training and Research Hospital Internal Diseases Polyclinic between 01 December 2016 and 01 June 2017 with a desire to lose weight was examined. Patients who were excluded from exclusion criteria and whose BMI was m2 25 kg / m2 were included in the study. Age, gender, curriculum vitae, blood pressure, anthropometric measurements and laboratory data recorded in patient files were used in the routine functioning of the Internal Diseases Polyclinic. Measurements and blood tests were done in the morning hours after at least 8 hours of fasting. The data of the study were analyzed using Statistical Package for the Social Sciences (SPSS) statistical package program.
Size E: 178.00 (165-186), K: 161.00 (150-185) (p <0.001) and body weight E: 100.00 (76-134), K: 87.00 (66-140 ) (p <0.001). Waist / hip circumference ratio was E: 0.88 ± 0.09, K: 0.83 ± 0.06 (p = 0.02). TPG K: 94.00 (61-218), E: 101.00 (70-219) (p = 0.05). HDL E: 41.00 (28-141), K: 48.00 (31-78) (p = <0.01). Vitamin B12 K: 215.00 (97-1500), E: 188.00 (107-394) (p: 0.04).
HOMA IR Overweight: 1.57 (0. 5-5.7), Stage 1 Obese: 2.19 (0.55-20.20), Stage 2 Obese: 2.80 (1.09- 12. 7), Stage 3 Obese: 3.06 (0.42-6.2 ) (p: 0.002).
Waist circumference; overweight: 89.86 ± 10.71, Stage 1: 95.30 ± 16.51, Stage 2: 104.52 ± 9.04, Stage 3 obese: 114.88 ± 11.75 (p <0.001). Hip circumference; overweight: 107.0 (97-125), Stage 1: 114.0 (96-134), Stage 2: 125.0 (101-140), Stage 3: 130.0 (111-150) (
1. Okka B, Durduran Y. Obesity in the Ancient Greek and Byzantine Periods. Turkiye Klinikleri J Med Ethics . 2013;21(3):111-117.
2. WHO Consultation on Obesity, World Health Organization, Programme of Nutrition, Family and Reproductive Health. Obesity : Preventing and Managing the Global Epidemic : Report of a WHO Consultation on Obesity.; 1997. Accessed July 25, 2024. https://iris.who.int/handle/10665/63854
3. World Health Organization. Obesity. Accessed July 25, 2024. https://www.who.int/health-topics/obesity#tab=tab_1
4. Gergerlioğlu U. Evaluation of Obesity Taxes in the Context of Some OECD Countries. Journal of Economic and Social Research. 2016;12(2):149-166.
5. Turkish Society of Cardiology. Coronary Heart Disease Prevention and Treatment Guidelines; 2002.
6. Haslam DW, James WPT. Obesity. Lancet. 2005;366(9492):1197-1209. doi:10.1016/S0140-6736(05)67483-1
8. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102-38. doi:10.1161/01.cir.0000437739.71477.ee
9. Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083-1096. doi:10.1016/S0140-6736(09)60318-4
10. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
11. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998;6 Suppl 2:51S-209S.
12. Bulur Ş, Çeçen S, Eren F. Anthropometric and Biochemical Characteristics of Individuals Applying to the Department of Sports Physiology with Overweight Complaint. Journal of ADU Faculty of Medicine. 2014;15(1):29-35.
13. Akbas F, Usta Atmaca H, Karadas E, Yildiz I, Okten IN. Evaluation of Data from the Obesity Outpatient Clinic at the End of the Second Year as a Newly Formed Unit in Istanbul Training and Research Hospital. Istanbul Medical Journal. 2013;14(4):253-256. doi:10.5152/imj.2013.69672
14. Turkey Health Survey; 2022. Accessed July 27, 2024. https://data.tuik.gov.tr/Bulten/Index?p=Turkiye-Saglik-Arastirmasi-2022-49747
15. Saygın M, Öztürk Ö, Akbulut S, Kılınç F, Saygın RR. Prevalence of obesity in patients applying to the diet outpatient clinic of Süleyman Demirel University Faculty of Medicine Hospital. SDU Medical Faculty Derg . 2015;22(3):53-59.
16. Altun B, Arici M, Nergizoglu G, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens. 2005;23(10):1817-1823. doi:10.1097/01.hjh.0000176789.89505.59
17. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377(1):13-27. doi:10.1056/NEJMoa1614362
18. Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA. 2009;302(4):401-411. doi:10.1001/jama.2009.1060
19. Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128(2):81-88. doi:10.7326/0003-4819-128-2-199801150-00001
20. Menke A, Rust KF, Fradkin J, Cheng YJ, Cowie CC. Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies. Ann Intern Med. 2014;161(5):328-335. doi:10.7326/M14-0286
21. Uusitupa M, Khan TA, Viguiliouk E, et al. Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis. Nutrients. 2019;11(11). doi:10.3390/nu11112611
22. Bogers RP, Bemelmans WJE, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167(16):1720-1728. doi:10.1001/archinte.167.16.1720
23. Bays HE, Kirkpatrick C, Maki KC, et al. Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. Obesity Pillars. 2024;10:100108. doi:10.1016/j.obpill.2024.100108
24. Uysal A. Investigation of the Correlation Between Obesity and Liver Function Tests in Obese Cases. Specialization Thesis. Taksim Training and Research Hospital; 2005.
25. Fishbein MH, Miner M, Mogren C, Chalekson J. The Spectrum of Fatty Liver in Obese Children and The Relationship of Serum Aminotransferases to Severity of Steatosis. J Pediatr Gastroenterol Nutr. 2003;36(1):54-61. doi:10.1097/00005176-200301000-00012
26. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem. 1991;37(5):720-723.
27. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney Int. 2008;73(1):19-33. doi:10.1038/sj.ki.5002586
28. Gómez-Ambrosi J, González-Crespo I, Catalán V, et al. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities. Clinical Nutrition. 2018;37(2):580-589. doi:10.1016/j.clnu.2017.01.010
29. Shen W wen, Chen H mei, Chen H, Xu F, Li L shi, Liu Z hong. Obesity-related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol. 2010;5(8):1401-1409. doi:10.2215/CJN.01370210
30. Walsh JS, Evans AL, Bowles S, et al. Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. Am J Clin Nutr. 2016;103(6):1465-1471. doi:10.3945/ajcn.115.120139
31. Walsh JS, Bowles S, Evans AL. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes. 2017;24(6):389-394. doi:10.1097/MED.0000000000000371
1.Mühürdaroğlu AM, Akdağ İ, Taştemur M. Determination of Etiology and Risk Factors in Patients Applying to Our Outpatient Clinic for Weight Loss. CMJ. 2024;46(3):198-204. doi:10.7197/cmj.1539734
